Frank Herting

Person

Sindelsdorf, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody fab and Fc variants
- Patent number 11,525,007
- Issue date Dec 13, 2022
- HOFFMANN-LA ROCHE INC.
- Peter Bruenker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating colon cancer or inhibiting cell proliferation...
- Patent number 11,512,133
- Issue date Nov 29, 2022
- HOFFMANN-LA ROCHE INC.
- Frank Herting
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the tre...
- Patent number 10,683,345
- Issue date Jun 16, 2020
- Roche Glycart AG
- Harald Duerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the tre...
- Patent number 9,695,233
- Issue date Jul 4, 2017
- Roche GlycArt AG
- Harald Duerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydroxamates, their manufacture and use as pharmaceutical agents
- Patent number 7,638,553
- Issue date Dec 29, 2009
- Hoffmann-La Roche Inc.
- Georg Fertig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mono-acylated o-phenylendiamines derivatives
- Patent number 7,501,451
- Issue date Mar 10, 2009
- Hoffmann-La Roche Inc.
- Georg Fertig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiophene hydroxamic acid derivatives and their use as HDAC inhibitors
- Patent number 7,423,060
- Issue date Sep 9, 2008
- Hoffman-La Roche Inc.
- Georg Fertig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiophene derivatives, their manufacture and use as pharmaceutical...
- Patent number 7,396,944
- Issue date Jul 8, 2008
- Hoffmann-La Roche Inc.
- Georg Fertig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-monoacylated o-phenylenediamines
- Patent number 7,208,491
- Issue date Apr 24, 2007
- Hoffmann-La Roche Inc.
- Georg Fertig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxime derivatives and their use as pharmaceutically active agents
- Patent number 7,173,060
- Issue date Feb 6, 2007
- Hoffmann-La Roche Inc.
- Georg Fertig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thiophene hydroxamic acid derivatives
- Patent number 7,098,241
- Issue date Aug 29, 2006
- Hoffmann-La Roche Inc.
- Adelbert Grossmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives
- Patent number 7,098,247
- Issue date Aug 29, 2006
- Hoffmann-La Roche Inc.
- Georg Fertig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mono-acylated o-phenylendiamines derivatives
- Patent number 7,071,219
- Issue date Jul 4, 2006
- Hoffmann-La Roche Inc.
- Georg Fertig
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS AND COMPOSITIONS COMPRISING A BRAF INHIBITOR AND A PD-1 BIN...
- Publication number 20240197735
- Publication date Jun 20, 2024
- HOFFMANN-LA ROCHE INC.
- Jan ECKMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS COMPRISING A BRAF INHIBITOR AND A MEK INHI...
- Publication number 20240139192
- Publication date May 2, 2024
- HOFFMANN-LA ROCHE INC.
- Jan ECKMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TRE...
- Publication number 20230212277
- Publication date Jul 6, 2023
- Hoffmann-La Roche Inc.
- Harald Duerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TRE...
- Publication number 20210095013
- Publication date Apr 1, 2021
- Roche Glycart AG
- Harald Duerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND ANTIBODI...
- Publication number 20200392234
- Publication date Dec 17, 2020
- HOFFMANN-LA ROCHE INC.
- Frank Herting
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY FAB AND FC VARIANTS
- Publication number 20190106502
- Publication date Apr 11, 2019
- HOFFMANN-LA ROCHE INC.
- Peter Bruenker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY FC AND FAB VARIANTS
- Publication number 20190092872
- Publication date Mar 28, 2019
- HOFFMANN-LA ROCHE INC.
- Peter Bruenker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND ANTIBODI...
- Publication number 20180346581
- Publication date Dec 6, 2018
- HOFFMANN-LA ROCHE INC.
- Frank Herting
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF ANTIBODY BINDING TO ANGIOPOIETIN 2 WITH ANTI...
- Publication number 20180155431
- Publication date Jun 7, 2018
- HOFFMANN-LA ROCHE INC.
- Frank Herting
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TRE...
- Publication number 20170260265
- Publication date Sep 14, 2017
- Roche Glycart AG
- Harald Duerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND ANTIBODI...
- Publication number 20170051065
- Publication date Feb 23, 2017
- HOFFMANN-LA ROCHE INC.
- Frank Herting
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy of an anti-CD20 antibody with a Bcl-2 inhibitor...
- Publication number 20160347852
- Publication date Dec 1, 2016
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE
- Publication number 20160166688
- Publication date Jun 16, 2016
- Roche Glycart AG
- FRANK HERTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH AN ANTI-VEGF
- Publication number 20160017050
- Publication date Jan 21, 2016
- Roche Glycart AG
- FRANK HERTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...
- Publication number 20160000911
- Publication date Jan 7, 2016
- Roche Glycart AG
- CHARLES DUMONTET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABI...
- Publication number 20150274834
- Publication date Oct 1, 2015
- Roche Glycart AG
- MARTIN DREYLING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR IN...
- Publication number 20150265703
- Publication date Sep 24, 2015
- Roche Glycart AG
- FRANK HERTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE
- Publication number 20150093376
- Publication date Apr 2, 2015
- Roche Glycart AG
- FRANK HERTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABI...
- Publication number 20150079073
- Publication date Mar 19, 2015
- Roche Glycart AG
- MARTIN DREYLING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy of antibodies against human CSF-1R and antibodi...
- Publication number 20150073129
- Publication date Mar 12, 2015
- HOFFMANN-LA ROCHE INC.
- Frank Herting
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR IN...
- Publication number 20150071911
- Publication date Mar 12, 2015
- Roche Glycart AG
- FRANK HERTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH AN ANTI-V...
- Publication number 20140322200
- Publication date Oct 30, 2014
- Roche Glycart AG
- FRANK HERTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MDM2 IN...
- Publication number 20140140988
- Publication date May 22, 2014
- Roche Glycart AG
- ERIC ELDERING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...
- Publication number 20140065134
- Publication date Mar 6, 2014
- Roche Glycart AG
- CHARLES DUMONTET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE
- Publication number 20140044705
- Publication date Feb 13, 2014
- Roche Glycart AG
- FRANK HERTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific Anti-VEGF/Anti-ANG-2 Antibodies and their use in the Tre...
- Publication number 20140017244
- Publication date Jan 16, 2014
- Harald Duerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABI...
- Publication number 20140010804
- Publication date Jan 9, 2014
- Roche Glycart AG
- MARTIN DREYLING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR IN...
- Publication number 20130280243
- Publication date Oct 24, 2013
- FRANK HERTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH AN ANTI-V...
- Publication number 20130183290
- Publication date Jul 18, 2013
- FRANK HERTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE
- Publication number 20120315268
- Publication date Dec 13, 2012
- FRANK HERTING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Frank Herting

Person

Patents Grantslast 30 patents

Antibody fab and Fc variants

Methods for treating colon cancer or inhibiting cell proliferation...

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the tre...

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the tre...

Hydroxamates, their manufacture and use as pharmaceutical agents

Mono-acylated o-phenylendiamines derivatives

Thiophene hydroxamic acid derivatives and their use as HDAC inhibitors

Thiophene derivatives, their manufacture and use as pharmaceutical...

N-monoacylated o-phenylenediamines

Oxime derivatives and their use as pharmaceutically active agents

Thiophene hydroxamic acid derivatives

Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives

Mono-acylated o-phenylendiamines derivatives

Patents Applicationslast 30 patents

METHODS AND COMPOSITIONS COMPRISING A BRAF INHIBITOR AND A PD-1 BIN...

METHODS AND COMPOSITIONS COMPRISING A BRAF INHIBITOR AND A MEK INHI...

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TRE...

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TRE...

COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND ANTIBODI...

ANTIBODY FAB AND FC VARIANTS

ANTIBODY FC AND FAB VARIANTS

COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND ANTIBODI...

COMBINATION THERAPY OF ANTIBODY BINDING TO ANGIOPOIETIN 2 WITH ANTI...

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TRE...

COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND ANTIBODI...

Combination therapy of an anti-CD20 antibody with a Bcl-2 inhibitor...

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH AN ANTI-VEGF

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABI...

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR IN...

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABI...

Combination therapy of antibodies against human CSF-1R and antibodi...

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR IN...

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH AN ANTI-V...

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MDM2 IN...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE

Bispecific Anti-VEGF/Anti-ANG-2 Antibodies and their use in the Tre...

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABI...

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR IN...

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH AN ANTI-V...

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE